Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.

Clinical trial NCT00354822 · TERMINATED

Trial details

NCT number: NCT00354822
Sponsor: A.O. Ospedale Papa Giovanni XXIII
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2005-08-01
Primary completion: 2009-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.